Gastric carcinoma exhibits distinct types of cell differentiation: an immunohistochemical study of trefoil peptides (TFF1 and TFF2) and mucins (MUC1,MUC2, MUC5AC, and MUC6)

Citation
Jc. Machado et al., Gastric carcinoma exhibits distinct types of cell differentiation: an immunohistochemical study of trefoil peptides (TFF1 and TFF2) and mucins (MUC1,MUC2, MUC5AC, and MUC6), J PATHOLOGY, 190(4), 2000, pp. 437-443
Citations number
32
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research Diagnosis & Treatment
Journal title
JOURNAL OF PATHOLOGY
ISSN journal
00223417 → ACNP
Volume
190
Issue
4
Year of publication
2000
Pages
437 - 443
Database
ISI
SICI code
0022-3417(200003)190:4<437:GCEDTO>2.0.ZU;2-E
Abstract
The expression of trefoil peptides (TFF1 and TFF2) and mucins (MUC1, MUC2, MUC5AC, and MUC6) has previously been described in gastric polyps. In the p resent study, the expression profile of these trefoil peptides and mucins w as characterized in 96 gastric carcinomas, in an attempt to further the und erstanding of the histogenesis and cell differentiation of gastric carcinom a. Taking together the co-expression of trefoil peptides and mucins, three phenotypes were defined: complete gastric, incomplete gastric, and non-gast ric phenotype, Gastric differentiation (complete and incomplete) was observ ed in 30 out of 33 (90.9%) diffuse carcinomas and in 38 out of 53 (71.7%) i ntestinal carcinomas. Non-gastric differentiation was observed in only thre e (9.1%) diffuse carcinomas and in 15 (28.3%) intestinal carcinomas, The ph enotypes observed in intestinal carcinomas were similar to those previously observed in adenomatous polyps, whereas most diffuse carcinomas mimicked t he phenotype of hyperplastic polyps, The percentage of cases displaying a n on-gastric phenotype was higher, though not significantly, in tumours that had invaded the gastric wall than in T1 tumours, regardless of histotype, I t is concluded that gastric-type differentiation is retained in the majorit y of gastric carcinomas, being more prominent in diffuse than in intestinal carcinomas, and in early than in advanced carcinomas. Copyright (C) 2000 J ohn Wiley & Sons, Ltd.